5Cesaro S, Marson P, Gazzola MV. et al. The use of cytokine-stimulated healthy donors in allogeneic stem celltransplantation[J]. Haematologica,2002 ,87(8 Suppl) : 35-41.
6Bonilla MA, Dale D,Zeidler C. et al. Long-term safety oftreatment with recombinant human granulocyte colony-stimulating factor ( r-metHuG-CSF) in patients with severecongenital neutropenias [J]. Br J Haematoh 1994, 88(4) : 723-730.
7Jiang X, LopezA, Holyoake T, et al. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 1999;96(22): 12804-12809.
8Pollmacher T, Korth C, Schreiber W, et al.Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels. Cytokine. 1996;8(10):799-803.
9Shimazaki C, Uchiyama H, Fujita N, et al. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation. Exp Hematol. 1995; 23(14):1497-1502.
10Dong F, Pouwels K, Hoefsloot LH, et al. The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells. Exp Hematol. 1996; 24(2):214-220.
